CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Deferred Income Taxes and Other Assets, Noncurrent
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Deferred Income Taxes and Other Assets, Noncurrent of $15.09 million as of 2022-09-24, per its 10-Q filed 2022-11-02.
Discontinued › Notes › and Other Assets
us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent · last filed 2022-11-02
- 2022-09-24: Deferred Income Taxes and Other Assets, Noncurrent $15.09M.
- 2022-06-25: Deferred Income Taxes and Other Assets, Noncurrent $16.41M.
- 2022-03-26: Deferred Income Taxes and Other Assets, Noncurrent $18.20M.
- 2021-12-25: Deferred Income Taxes and Other Assets, Noncurrent $18.69M.
| Period end | Deferred Income Taxes and Other Assets, Noncurrent |
|---|---|
| 2022-09-24 | $15.09M 10-Q · filed 2022-11-02 |
| 2022-06-25 | $16.41M 10-Q · filed 2022-08-03 |
| 2022-03-26 | $18.20M 10-Q · filed 2022-05-04 |
| 2021-12-25 | $18.69M 10-Q · filed 2022-11-02 |
| 2021-09-25 | $22.64M 10-Q · filed 2021-11-03 |
| 2021-06-26 | $23.15M 10-Q · filed 2021-08-04 |
| 2021-03-27 | $22.83M 10-Q · filed 2021-05-04 |
| 2020-12-26 | $23.48M 10-K · filed 2022-02-16 |
| 2020-09-26 | $21.38M 10-Q · filed 2020-10-29 |
| 2020-06-27 | $20.63M 10-Q · filed 2020-08-05 |
| 2020-03-28 | $20.53M 10-Q · filed 2020-05-07 |
| 2019-12-28 | $20.57M 10-K · filed 2021-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |